BOC Group "disappointed" with Illinois appeals court decision
The BOC Group plc is disappointed with the decision of the appeal court in Illinois confirming the decision of the trial court in the Elam case tried in Madison County, Illinois in 2003. The BOC Group, Inc. a US subsidiary of BOC – was one of three defendants.
BOC's a huge company, concentrating on compressed and Packaged gases, equipment and related products and service. This includes a range of products including compressed gases, special and medical gases and LPG, as well as smaller sales of bulk liquefied gases. Sales are mainly to customers in the fabrication, medical and scientific sectors.
BOC’s position on manganese litigation is to defend themselves vigorously against what the company believes to be meritless claims. The BOC Group, Inc. and the other defendants intend to appeal the Elam decision to the Illinois Supreme Court. That court has discretion to decide whether to accept the appeal.
Since 2003, there have been a number of scientific studies that indicate no increased risk of Parkinson’s disease or related disease among welders. These studies include a study conducted among 27,839 workers in Denmark, including 6,163 welders, which concludes welders are not at increased risk of developing Parkinson’s disease or other neurodegenerative disorders, and a study conducted in the United States at three Caterpillar Inc. plants of 12,595 workers, of which 3,430 were welders. This study also found no statistically significant increased risk of disease among welders.
As of September 30, 2005, there were 8,500 manganese claimants naming BOC Group as a defendant. As of today, BOC's stock is at $41.04.
BOC's a huge company, concentrating on compressed and Packaged gases, equipment and related products and service. This includes a range of products including compressed gases, special and medical gases and LPG, as well as smaller sales of bulk liquefied gases. Sales are mainly to customers in the fabrication, medical and scientific sectors.
BOC’s position on manganese litigation is to defend themselves vigorously against what the company believes to be meritless claims. The BOC Group, Inc. and the other defendants intend to appeal the Elam decision to the Illinois Supreme Court. That court has discretion to decide whether to accept the appeal.
Since 2003, there have been a number of scientific studies that indicate no increased risk of Parkinson’s disease or related disease among welders. These studies include a study conducted among 27,839 workers in Denmark, including 6,163 welders, which concludes welders are not at increased risk of developing Parkinson’s disease or other neurodegenerative disorders, and a study conducted in the United States at three Caterpillar Inc. plants of 12,595 workers, of which 3,430 were welders. This study also found no statistically significant increased risk of disease among welders.
As of September 30, 2005, there were 8,500 manganese claimants naming BOC Group as a defendant. As of today, BOC's stock is at $41.04.
posted by Scott at 4:24 PM
0 Comments:
Post a Comment
<< Home